Dr. Reddy's Laboratories terminated its distribution and promotion agreement with Novartis India Limited for select brands in India, following a change in Novartis India's controlling shareholding. The company will continue to commercialize the affected brands until September 30, 2026. Dr. Reddy's Laboratories is a pharmaceutical company engaged in the research, development, and manufacturing of generic medicines.
